Empowered Funds
RXST icon

Empowered Funds’s RxSight RXST Stock Holding History

Empowered Funds’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$245K Buy
+50,000
New +$293K ﹤0.01% 2137

Other funds holding RXST

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Empowered Funds's RXST Position: Q3 2026 in Review

Empowered Funds opened a new position in RxSight (RXST) in Q3 2026: 50,000 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #2137 among its holdings.

97 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Empowered Funds held 50,000 shares of RxSight worth $245K as of Q3 2026.
  • RxSight was a new Empowered Funds position in Q3 2026.
  • RxSight made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2137 holding.
  • 97 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.